Media coverage
15
Media coverage
Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet Morningstar.com Country/Territory United States Date 15/03/22 URL https://www.morningstar.com/news/globe-newswire/8503140/nuwellis-announces-irb-approval-to-begin-its-reverse-hf-clinical-study Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet Street Insider Country/Territory United States Date 15/03/22 URL https://www.streetinsider.com/Globe+Newswire/Nuwellis+Announces+IRB+Approval+to+Begin+Its+REVERSE-HF+Clinical+Study/19774646.html Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 15/03/22 Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet ADVFN UK Country/Territory United Kingdom Date 15/03/22 URL https://uk.advfn.com/stock-market/NASDAQ/NUWE/share-news/Nuwellis-Announces-IRB-Approval-to-Begin-Its-REVER/87554632 Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet Yahoo! Canada Country/Territory Canada Date 15/03/22 URL https://ca.sports.yahoo.com/news/nuwellis-announces-irb-approval-begin-110000971.html Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet Yahoo! Finance Country/Territory United States Date 15/03/22 URL https://finance.yahoo.com/news/nuwellis-announces-irb-approval-begin-110000971.html Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet ADVFN US Country/Territory United States Date 15/03/22 URL https://www.advfn.com/p.php?pid=nmona&article=87554632 Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet Wallstreet Online Country/Territory Germany Date 15/03/22 URL https://www.wallstreet-online.de/nachricht/15184098-nuwellis-announces-irb-approval-to-begin-its-reverse-hf-clinical-study Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet India Pharma News Country/Territory India Date 15/03/22 Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Coronary/Structural Heart March 15, 2022 Media name/outlet Cardiac Vascular News Country/Territory United States Date 15/03/22 URL cardiacvascularnews.com/nuwellis-announces-irb-approval-to-begin-its-reverse-hf-clinical-study/ Persons Sean Pinney Title IRB Approval to Begin Its REVERSE HF Clinical Study Media name/outlet Market News Publishing Country/Territory United States Date 15/03/22 Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet Cardiac Vascular News Country/Territory United States Date 15/03/22 URL cardiacvascularnews.com/nuwellis-announces-irb-approval-to-begin-its-reverse-hf-clinical-study/ Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet GlobeNewswire Country/Territory United States Date 15/03/22 URL https://www.globenewswire.com/news-release/2022/03/15/2403219/26106/en/Nuwellis-Announces-IRB-Approval-to-Begin-Its-REVERSE-HF-Clinical-Study.html Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study; The REVERSE-HF study will evaluate ultrafiltration therapy for heart failure patients suffering from fluid overload Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 15/03/22 Persons Sean Pinney Title Nuwellis Announces IRB Approval to Begin Its REVERSE-HF Clinical Study Media name/outlet BizWire Express Country/Territory India Date 15/03/22 URL www.bizwireexpress.com/showstoryGNW.php?storyid=356653 Persons Sean Pinney